Radiotherapy Quality Assurance (RTQA) of Concurrent Chemoradiotherapy for Locally Advanced Non–Small Cell Lung Cancer in the PROCLAIM Phase 3 Trial

Results from PROCLAIM study, the largest global randomized study using RTQA in Stage III NSCLC, showed poorer outcomes at centers with multiple major violations. Those findings are hypothesis-generating and support the importance of real-time RTQA in future randomized trials. Real-time RTQA can play an important role in improving overall RT quality for patients entered and treated on studies.

https://ift.tt/2GSGCn7